Literature DB >> 30352286

Bioresorbable electrospun gelatin/polycaprolactone nanofibrous membrane as a barrier to prevent cardiac postoperative adhesion.

Bei Feng1, Shoubao Wang2, Dongjian Hu3, Wei Fu4, Jinglei Wu5, Haifa Hong4, Ibrahim J Domian3, Fen Li6, Jinfen Liu7.   

Abstract

Post-cardiac surgical sternal and epicardial adhesions increase the risk and complexity of cardiac re-operative surgeries, which represent a significant challenge for patients with the congenital cardiac disease. Bioresorbable membranes can serve as barriers to prevent postoperative adhesions. Herein, we fabricated a bioresorbable gelatin/polycaprolactone (GT/PCL) composite membrane via electrospinning. The membrane was characterized in terms of morphology, mechanical properties, and biocompatibility. We then evaluated its efficacy as a physical barrier to prevent cardiac operative adhesions in a rabbit model. Our results showed that the membrane had a nanofibrous structure and was sturdy enough to be handled for the surgical procedures. In vitro studies with rabbit cardiac fibroblasts demonstrated that the membrane was biocompatible and inhibited cell infiltration. Further application of the membrane in a rabbit cardiac adhesion model revealed that the membrane was resorbed gradually and effectively resisted the sternal and epicardial adhesions. Interestingly, six months after the operation, the GT/PCL membrane was completely resorbed with simultaneous ingrowth of host cells to form a natural barrier. Collectively, these results indicated that the GT/PCL membrane might be a suitable barrier to prevent sternal and epicardial adhesions and might be utilized as a novel pericardial substitute for cardiac surgery. STATEMENT OF SIGNIFICANCE: Electrospinning is a versatile method to prepare nanofibrous membranes for tissue engineering and regenerative medicine applications. However, with the micro-/nano-scale structure and high porosity, the electrospun membrane might be an excellent candidate as a barrier to prevent postoperative adhesion. Here we prepared an electropun GT/PCL nanofibrous membrane and applied it as a barrier to prevent sternal and epicardial adhesions. Our results showed that the membrane had sufficient mechanical strength, good biocompatibility, and effectively resisted the sternal and epicardial adhesions. What's more, the membrane was bioresorbable and allowed simultaneous ingrowth of host cells to form a natural barrier. We believe that the current will inspire more research on nanomaterials to prevent postoperative adhesion applications.
Copyright © 2018 Acta Materialia Inc. All rights reserved.

Entities:  

Keywords:  Bioresorbable; Congenital cardiac disease; Electrospinning; Gelatin/polycaprolactone membrane; Postoperative adhesions

Mesh:

Substances:

Year:  2018        PMID: 30352286     DOI: 10.1016/j.actbio.2018.10.022

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  11 in total

1.  Development and Characterization of Multifunctional Wound Dressing with the Property of Anti-bacteria and Angiogenesis.

Authors:  Xi He; Meiling Zhou; Xuemei Chen; Jing Wang; Xiaoli Zhao; Yanxia Zhu; Tao Liu
Journal:  Probiotics Antimicrob Proteins       Date:  2022-03-02       Impact factor: 4.609

2.  Regulation of ERK1/2 and SMAD2/3 Pathways by Using Multi-Layered Electrospun PCL-Amnion Nanofibrous Membranes for the Prevention of Post-Surgical Tendon Adhesion.

Authors:  Chunjie Liu; Siyu Tian; Jiangbo Bai; Kunlun Yu; Lei Liu; Guoli Liu; Ruiyi Dong; Dehu Tian
Journal:  Int J Nanomedicine       Date:  2020-02-11

3.  Characteristics and toxicity assessment of electrospun gelatin/PCL nanofibrous scaffold loaded with graphene in vitro and in vivo.

Authors:  Xi Chen; Bei Feng; Di-Qi Zhu; Yi-Wei Chen; Wei Ji; Tian-Ji Ji; Fen Li
Journal:  Int J Nanomedicine       Date:  2019-05-21

Review 4.  Core-Shell Fibers: Design, Roles, and Controllable Release Strategies in Tissue Engineering and Drug Delivery.

Authors:  Muhammad Faiq Abdullah; Tamrin Nuge; Andri Andriyana; Bee Chin Ang; Farina Muhamad
Journal:  Polymers (Basel)       Date:  2019-12-04       Impact factor: 4.329

Review 5.  New Forms of Electrospun Nanofibers Applied in Cardiovascular Field.

Authors:  Weimin Huang; Mengen Huo; Nan Cheng; Rong Wang
Journal:  Front Cardiovasc Med       Date:  2022-01-21

6.  Gelatin/Polycaprolactone Electrospun Nanofibrous Membranes: The Effect of Composition and Physicochemical Properties on Postoperative Cardiac Adhesion.

Authors:  Xingang Wang; Li Xiang; Yongxuan Peng; Zihao Dai; Yuqing Hu; Xiaoting Pan; Xingliang Zhou; Hao Zhang; Bei Feng
Journal:  Front Bioeng Biotechnol       Date:  2021-12-06

7.  Application of ANN modeling techniques in the prediction of the diameter of PCL/gelatin nanofibers in environmental and medical studies.

Authors:  Saba Kalantary; Ali Jahani; Reza Pourbabaki; Zahra Beigzadeh
Journal:  RSC Adv       Date:  2019-08-12       Impact factor: 4.036

8.  An innovative bioresorbable gelatin based 3D scaffold that maintains the stemness of adipose tissue derived stem cells and the plasticity of differentiated neurons.

Authors:  Catherine Ann Martin; Subathra Radhakrishnan; Sakthivel Nagarajan; Shanthini Muthukoori; J M Meseguer Dueñas; José Luis Gómez Ribelles; Baddrireddi Subhadra Lakshmi; Nivethaa E A K; José Antonio Gómez-Tejedor; Mettu Srinivas Reddy; Shanmugaapriya Sellathamby; Mohamed Rela; Narayana Kalkura Subbaraya
Journal:  RSC Adv       Date:  2019-05-08       Impact factor: 4.036

9.  Enhancement of Tendon Repair Using Tendon-Derived Stem Cells in Small Intestinal Submucosa via M2 Macrophage Polarization.

Authors:  Xufeng Mao; Liwei Yao; Mei Li; Xiqian Zhang; Bowen Weng; Weilai Zhu; Renhao Ni; Kanan Chen; Linhua Yi; Jiyuan Zhao; Haijiao Mao
Journal:  Cells       Date:  2022-09-05       Impact factor: 7.666

10.  Adipose-derived mesenchymal stem cell seeded Atelocollagen scaffolds for cardiac tissue engineering.

Authors:  Qiong Li; Miaomiao Li; Meng Li; Zhengyan Zhang; Han Ma; Liang Zhao; Min Zhang; Guodong Wang
Journal:  J Mater Sci Mater Med       Date:  2020-09-23       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.